Relapsing Multiple Sclerosis trials recruiting in Ohio

All Relapsing Multiple Sclerosis trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
  NCT06433752 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Centerville, Cincinnati, Cleveland, Columbus
• Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
  NCT04047628 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Ohio: Cincinnati, Cleveland
• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
  NCT06846281 · Phase: Phase 3 · Ages: 40 Years to 70 Years · Sex: All (male and female) · Ohio: Centerville, Cincinnati, Cleveland, Columbus
• Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
  NCT06529406 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cleveland
• Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
  NCT05877963 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Ohio: Cincinnati, Cleveland, Dayton